Navidea Biopharmaceuticals (NAVB) Surges: Stock Moves 10.2% Higher – Tale of the Tape

December 5, 2013 Technicals 0

Zacks

Navidea Biopharmaceuticals, Inc. (NAVB) was a big mover last session, as the company saw its shares rise by over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 30% since Nov 20.

This medical appliances & equipment company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Navidea Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the medical instrument industry include Natus Medical Inc. (BABY), Cynosure, Inc. (CYNO) and CryoLife Inc. (CRY). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply